Q: Royalty Pharma plc. This IPO`d today. What are your thoughts on this? The royalty models seems very successful in different industries like precious metals.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi guys can you please give me advise on this company would it be a buy or stay away. thks
Q: I see you like this company, with good reason. I also see that it spent most of 2019 consolidating and that it is now retracing from an obviously overbought price level. Considering the company's fundamentals; revenue growth, earnings growth, and such other factors as you consider pertinent, at what price levels would you consider entry represented a significantly attractive opportunity. Please include market sentiment in your evaluation by assigning a price bracket to your response. Thank you.
Q: Can you see a reason why these shares are again up so strongly today 9%+ on huge relative volume. You had mentioned there are three analysts covering these shares. I only see Beacon on the TD system. Has there been an additional stimulus like an additional analysts recommendation.
Could you also mention what the other analysts targets are and do you see these as being reasonable based on the projection of doubling of revenue next quarter. Thank you for your excellent service.
Could you also mention what the other analysts targets are and do you see these as being reasonable based on the projection of doubling of revenue next quarter. Thank you for your excellent service.
Q: Sold long term income position JNJ due to concerns with law suits, Looking for a replacement in the same sector, already own GUD and MRK.
Considering ABBV, PFE or MDT, please provide your preference on these and if there is other recommendation for long term income hold.
Please provide a bit of rationale in your choice.
Thanks
Considering ABBV, PFE or MDT, please provide your preference on these and if there is other recommendation for long term income hold.
Please provide a bit of rationale in your choice.
Thanks
Q: Would you prefer HHL or LIFE as a potential investment? Income is a significant consideration for me. Thanks.
Q: Hi Peter,
I am researching some companies in the medical aesthetics space (INMD, CUTR, VERO, AGN, EOLS) and was wondering in this space, what multiple do companies typically trade at from a few different key metrics such as price to sales, P/E ratio, and any other metrics that you feel would be relevant to this space from a valuation perspective? Thanks.
I am researching some companies in the medical aesthetics space (INMD, CUTR, VERO, AGN, EOLS) and was wondering in this space, what multiple do companies typically trade at from a few different key metrics such as price to sales, P/E ratio, and any other metrics that you feel would be relevant to this space from a valuation perspective? Thanks.
Q: Please evaluate Novocare as a potential growth stock. Comments I have read are below and it would be great to hear if you see potential for this to rise as we get back to treating "elective" issues.
Unfortunately, the pandemic has delayed enrollment in some clinical trials. But ultimately, this is the only company with a "fourth modality" of cancer treatment beyond surgery, radiation, and chemotherapy — and with no competitors in sight.
Thanks!
Unfortunately, the pandemic has delayed enrollment in some clinical trials. But ultimately, this is the only company with a "fourth modality" of cancer treatment beyond surgery, radiation, and chemotherapy — and with no competitors in sight.
Thanks!
Q: With apologies to the members who do not appreciate US content, I am hopeful to get your thoughts on Quidel. How would you assess its potential for capital appreciation in the next year or two? There is a Covid angle which is almost a reason not to buy in my opinion (it has to end right?) but other business opportunities as well. Thoughts on whether to buy, sell or hold and why if you can please.
Q: would it be to late to purchase Abbvie after this big run in price.
Q: There has been quite a fall in ATE's share price in the last week. Do you have any information on this? Do you see any upside, or is it time to let it go?
Q: With Endo's latest issues and a multi year low for their stock price, is it time to act for Mr Goodman? It would be great for GUD to go after the Paladin business. Endo needs the cash.
Can they do it? Should they?
Can they do it? Should they?
Q: Sorrento Therapeutics Inc. is hot on the Vaccine trail. along with MRNA & NVAX. Would you have an opinion on it?
Thanks! Austin
Thanks! Austin
Q: I am interested in WELL and have been watching it for some time, but I have one nagging question I wanted to ask. I was part of the PHM hype a few years ago and was flying high (like everyone) until it came crashing down. The hype around WELL as well as being in the healthcare space reminds me a lot of PHM. But is that where the similarities end? Do you like it at today's levels? Thanks.
Q: what is going on with this stock
Q: What is your outlook for prn ?
Q: Would you give me your opinion on Titan Medical for a longer tern buy? Thank you. cheers
Q: Can you give me your opinion on CloudMD?
Q: Any reason not to sell xhc and buy life. I want stability but income is very important. Thanks, J
Q: Hi 5i,
I have held GILD for a number of years, and now that a merger is announced would it be a buy, sell or hold. Do mergers of equal typically result in higher stock purchase prices?
I have held GILD for a number of years, and now that a merger is announced would it be a buy, sell or hold. Do mergers of equal typically result in higher stock purchase prices?